Andrew I. Koven, President & Chief Business Officer at Aralez Pharmaceuticals Inc. (ARLZ), sold 323,812 shares at $1.28 ($414K) on 2017-06-05, disclosed to the SEC on 2017-06-06.
Open-market sale of $414k ARLZ by President & Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.28 | 161,906 | $207K | 50.0% |
| 2 | $1.28 | 161,906 | $207K | 50.0% |
| Total | $1.28 avg | 323,812 | $414K | 100% |
| Filing → |
| ARLZ | SELL | 2018-03-21 | $17K | — | Filing → |
| ARLZ | SELL | 2017-03-22 | $19K | — | Filing → |
| ARLZ | BUY | 2017-03-17 | $51K | — | Filing → |